Chronic cough, a persistent and debilitating condition, poses a significant diagnostic challenge to clinicians due to its multifactorial origin. This article aims to elucidate an integrative approach to diagnosing and managing chronic cough, enhancing patient outcomes and reducing healthcare costs.
Chronic cough, defined as a cough lasting more than eight weeks, is a common presentation in primary care settings. The condition can significantly impair quality of life, leading to physical discomfort, social embarrassment, and sleep disruption. Despite its prevalence, the pathophysiology of chronic cough remains poorly understood, making diagnosis and treatment complex.
A comprehensive patient history and physical examination are paramount in diagnosing chronic cough. The clinician should explore common causes such as upper airway cough syndrome, gastroesophageal reflux disease, and asthma. Atypical presentations may warrant further investigations, including imaging studies and pulmonary function tests, to exclude less common etiologies like bronchiectasis and lung cancer.
Management of chronic cough should be individualized and based on the underlying cause. Empirical therapy for common causes can be initiated while awaiting diagnostic results. Refractory cases may require specialist referral for further evaluation and treatment. Non-pharmacological interventions, such as speech and physical therapy, can also play a crucial role in managing chronic cough.
Emerging research is shedding light on the neurogenic basis of chronic cough, opening avenues for novel therapeutic interventions. Further, the development of validated cough assessment tools will aid in standardizing the diagnosis and monitoring of treatment response.
In conclusion, chronic cough requires a comprehensive diagnostic approach and individualized management strategies. As our understanding of this condition evolves, it is hoped that novel therapeutic interventions will improve patient outcomes and enhance clinical practice.
1.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
2.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
3.
Year in Review: Non-Small Cell Lung Cancer
4.
FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.
5.
Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML
1.
Targeted Therapies for Breast Cancer: What’s New?
2.
Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer
3.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
4.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
5.
Sorafenib: Understanding the science behind a powerful cancer drug
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
4.
Common Cancer Myths Debunked
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation